247 related articles for article (PubMed ID: 3555030)
1. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q
Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030
[TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin: an update on clinical experience.
Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial.
Goldstein EJ; Kahn RM; Alpert ML; Ginsberg BP; Greenway FL; Citron DM
Am J Med; 1987 Apr; 82(4A):284-7. PubMed ID: 3555049
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan.
Kobayashi H
Am J Med; 1987 Apr; 82(4A):169-73. PubMed ID: 3555031
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
[TBL] [Abstract][Full Text] [Related]
6. A comparative randomized double-blind clinical trial of pivampicillin and ampicillin in lower respiratory tract infections.
Dewan J; Malik SK; Jindal SK; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):85-7. PubMed ID: 7037662
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis.
Esposito S; Galante D; Bianchi W; Gagliardi R
Am J Med; 1987 Apr; 82(4A):211-4. PubMed ID: 3555038
[TBL] [Abstract][Full Text] [Related]
8. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
[TBL] [Abstract][Full Text] [Related]
9. Treatment of nongonococcal urethritis with ciprofloxacin.
Fong IW; Linton W; Simbul M; Thorup R; McLaughlin B; Rahm V; Quinn PA
Am J Med; 1987 Apr; 82(4A):311-6. PubMed ID: 3555054
[TBL] [Abstract][Full Text] [Related]
10. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections.
Khan FA; Basir R
Chest; 1989 Sep; 96(3):528-37. PubMed ID: 2670465
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
Fass RJ
Am J Med; 1987 Apr; 82(4A):202-7. PubMed ID: 3555037
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.
Pichler HE; Diridl G; Stickler K; Wolf D
Am J Med; 1987 Apr; 82(4A):329-32. PubMed ID: 3555057
[TBL] [Abstract][Full Text] [Related]
13. Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.
Nix DE; Sands MF; Peloquin CA; Vari AJ; Cumbo TJ; Vance JW; Fracasso JE; Schentag JJ
Am J Med; 1987 Apr; 82(4A):352-6. PubMed ID: 3555060
[TBL] [Abstract][Full Text] [Related]
14. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
Jauregui L; Minns P; Hageage G
Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
[TBL] [Abstract][Full Text] [Related]
15. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of talampicillin and ampicillin in general practice.
Jaffé G; Murphy JE; Robinson OP
Practitioner; 1976 Apr; 216(1294):455-60. PubMed ID: 1273032
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of ciprofloxacin in lower respiratory tract infections.
Pedersen SS
Scand J Infect Dis Suppl; 1989; 60():89-97. PubMed ID: 2667111
[TBL] [Abstract][Full Text] [Related]
18. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
19. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
[TBL] [Abstract][Full Text] [Related]
20. Brodimoprim: therapeutic efficacy and safety in the treatment of bacterial infections.
Braunsteiner AR; Finsinger F
J Chemother; 1993 Dec; 5(6):507-11. PubMed ID: 8195846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
